The relationship between alexithymia and general symptoms of patients with depressive disorders

Psychiatry Investigation

Volumn 5, Issue 3, 2008, Pages 179-185

  Kim, Ju Hee ^a   Lee, Seung Jae ^a   Rim, Hyo Deog ^a   Kim, Hea Won ^a   Bae, Geum Ye ^a   Chang, Sung Man ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Alexithymia; Depression; Symptom Checklist 90 Revised; Symptomatology; Toronto Alexithymia Scale 20

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; BUSPIRONE; CITALOPRAM; CLONAZEPAM; DIAZEPAM; ESCITALOPRAM; FLUOXETINE; MIRTAZAPINE; OLANZAPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; SERTRALINE; TRAZODONE; VENLAFAXINE;

ADULT; AGED; ALEXITHYMIA; ANXIETY; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT CODING; PHOBIA; PSYCHOSIS; REGRESSION ANALYSIS; SCORING SYSTEM; SYMPTOM; SYMPTOM CHECKLIST 90;

EID: 54549099074     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: 10.4306/pi.2008.5.3.179     Document Type: Article

References (30)

1. Nemiah JC, Sifneos PE. Psychosomatic illness: a problem in communication. Psychother Psychosom 1970;18:154-160.
2. Sifneos PE. Alexithymia: past and present. Am J Psychiatry 1996;153 (7 Suppl):137-142.
3. Bagby RM, Parker JD, Taylor GJ. The twenty-item Toronto Alexithymia Scale - I. Item selection and cross-validation of the factor structure. J Psychosom Res 1994;38:23-32.
4. Honkalampi K, Hintikka J, Laukkanen E, Lehtonen J, Viinamäki H. Alexithymia and depression: a prospective study of patients with major depressive disorder. Psychosomatics 2001;42:229-234.
5. Honkalampi K, Saarinen P, Hintikka J, Virtanen V, Viinamäki H. Factors associated with alexithymia in patients suffering from depression. Psychother Psychosom 1999;68:270-275.
6. Saarijärvi S, Salminen JK, Toikka TB. Alexithymia and depression: a 1-year follow-up study in outpatients with major depression. J Psychosom Res 2001;51:729-733.
7. Hintikka J, Honkalampi K, Lehtonen J, Viinamäki H. Are alexithymia and depression distinct or overlapping constructs?: a study in a general population. Compr Psychiatry 2001;42:234-239.
8. Honkalampi K, Hintikka, J, Tanskanen A, Lehtonen J, Viinamäki H. Depression is strongly associated with alexithymia in the general population. J Psychosom Res 2000;48:99-104.
9. Honkalampi K, Koivumaa-Honkanen H, Tanskanen A, Hintikka J, Lehtonen J, Viinamäki H. Why do alexithymic features appear to be stable? A 12-month follow-up study of a general population. Psychother Psychosom 2001;70:247-253.
10. Bankier B, Aigner M, Bach M. Alexithymia in DSM-IV disorder: comparative evaluation of somatoform disorder, panic disorder, obsessive-compulsive disorder, and depression. Psychosomatics 2001;42:235-240.
11. Duddu V, Isaac MK, Chaturvedi SK. Alexithymia in somatoform and depressive disorders. J Psychosom Res 2003;54:435-438.
12. Haviland MG, Shaw DG, Cummings MA, MacMurray JP. Alexithymia: subscales and relationship to depression. Psychother Psychosom 1988;50:164-170.
13. Ohayon MM, Schatzberg AF. Prevalence of depressive episodes with psychotic features in the general population. Am J Psychiatry 2002;159: 1855-1861.
14. Coryell W, Pfohl B, Zimmerman M. The clinical and neuroendocrine features of psychotic depression. J Nerv Ment Dis 1984;172:521-528.
15. Fawcett J, Kravitz HM. Anxiety syndromes and their relationship to depressive illness. J Clin Psychiatry 1983;44(8 Pt 2):8-11.
16. Grabe HJ, Spitzer C, Freyberger HJ. Alexithymia and personality in relation to dimensions of psychopathology. Am J Psychiatry 2004;161: 1299-1301.
17. Lee YH, Rim HD, Lee JY. Development and validation of a Korean version of the 20-item Toronto Alexithymia Scale (TAS-20K). J Korean Neuropsychiatr Assoc 1996;35:888-899.
18. Kim KI, Kim JH, Won HT. Korean manual of Symptom Checklist-90-Revision. Seoul: Jung Ang Juk Sung Publisher; 1984.
19. Taylor GJ, Bagby RM, Parker JDA. Disorders of affect regulation: Alexithymia in Medical and Psychiatric Illness. Cambridge: UK Cambridge University Press; 1997.
20. Derogatis LR, Rickels K, Rock AF. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry 1976; 128:280-289.
21. Guy W. ECDEU assessment manual for psychopharmacology- revised: NIMH publ. (DHEW Publ. No ADM 76-338); 1976.
22. Sayar K, Ak I. The predictors of somatization: a review. Bull Clin Psychophar 2001;11:266-271.
23. Nkam I, Langlois-Thery S, Dollfus S, Petit M. Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients. Encephale 1997;23:267-272.
24. Stanghellini G. Language capacity in paranoid and non-paranoid schizophrenics: a revision of previous findings through the analysis of a larger sample. Neurol Psychiatr Brain Res 1995;3:229-236.
25. Stanghellini G, Ricca V. Alexithymia and schizophrenias. Psychopathology 1995;28:263-272.
26. Maggini C, Raballo A, Pelizza L, Paini M, Croci R. Subjective experience of language impairment and psychopathology in schizophrenia. Psychopathology 2003;36:17-22.
27. Todarello O, Porcelli P, Grilletti F, Bellomo A. Is alexithymia related to negative symptoms of schizophrenia? A preliminary longitudinal study. Psychopathology 2005;38:310-314.
28. Devine H, Stewart SH, Watt MC. Relations between anxiety sensitivity and dimensions of alexithymia in a young adult sample. J Psychosom Res 1999;47:145-158.
29. Berthoz S, Consoli S, Perez-Diaz F, Jouvent R. Alexithymia and anxiety: compounded relationships? A psychometric study. Eur Psychiatry 1999;14:372-378.
30. Taylor GJ, Parker JD, Bagby RM, Acklin MW. Alexithymia and somatic complaints in psychiatric out-patients. J Psychosom Res 1992; 36:417-424.